ArticleCancers2021

Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug Combinations.

Serena Stamatakos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.